Global air fluidized therapy bed sales are expected to reach US$ 653.5 million in 2023, forecast to grow at a CAGR of 5.7% to be valued at US$ 1,135 million from 2023 to 2033. Air fluidized therapy beds have shown an overall growth of a 4.1% CAGR from 2018 to 2022.
Due to the increasing number of accidents and injuries, it has become an important priority for medical centers to provide comfortable and safe resting areas for their patients, which is why demand for air fluidized therapy beds is growing in the market. The technology used in the beds and their comfort are the factors that help beds thrive in an increasingly competitive market.
A growing need for advanced and cutting-edge healthcare products has contributed to the growth of air fluidized therapy beds worldwide. To treat patients with utmost comfort, hospitals and home care providers are placing significant trust in these beds.
Using air fluidized bed therapy is a beneficial way for those who have wounds, ulcers, and other illnesses, and those who are also suffering from intense pain to be relieved. These beds are also used by patients who are suffering from air fluidized bed therapy. A fluidized air bed therapy is mainly used for the treatment of wounds and other skin-related health conditions. As a result, the players are delivering the beds based on the indications.
To treat the skin, air fluidized beds are specially designed to provide a therapeutic level of moisture and other conditions based on the patient's needs. By reducing the pressure and sharing inside the bed, the airflow inside the bed promotes better sleep for all the body parts. In addition to pressure dynamic and temperature controllers, a variety of sensors are being developed for the comfort of patients.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
With the growing number of diseases, hospitals must provide better conditions for patients to recover. Air fluidized therapy beds are a great solution for this requirement since they provide suitable air circulation and treatment for patients in medical facilities. As a clinical benefit, AFT reduces the number of hospitalizations and emergency room visits for patients with pressure ulcers who are in long-term care facilities.
In addition, these beds decrease mortality rates among patients who have extensive burns and inhalation injuries and promote rapid healing and greater comfort among patients with burn injuries. As medical centers place utmost emphasis on patient comfort, air fluidized therapy beds are likely to gain great popularity shortly.
They reduce friction, shear, and pressure on the patient, so they get a better chance of recovering faster. Increasing technological innovation and advancement in treatments have made these beds in great demand at hospitals worldwide. Furthermore, for patients with skin-related issues, the demand for less noisy and comfortable beds has helped drive the air fluidized therapy bed market.
AHRQ (Agency for Healthcare Research & Quality) estimates that 2.5 million Americans suffer from pressure ulcers every year. As key companies in the fields prepare battery-operated beds that provide comfort to bedridden patients, the need for comfortable beds has also increased.
| Attributes | Value |
|---|---|
| Air Fluidized Therapy Bed Market Size (2023) | US$ 653.5 million |
| Air Fluidized Therapy Bed Market Projected Size (2033) | US$ 1,135 million |
| Air Fluidized Therapy Bed Market CAGR (2023 to 2033) | 5.7% |
While air fluidized therapy beds have many benefits for medical treatment, there are also a few factors that hinder their growth in the market. It is contraindicated to use air fluidized beds for patients with unstable spines, as the lack of adequate back support causes prolonged coughing for the patient. This impedes the market growth for these beds in the market.
In addition, patients who suffer from pulmonary secretion diseases or have trouble moving should refrain from using these beds to maintain their better health. Although this is not a constraint, in the long run, it limits the growth of air fluidized therapy beds in the market.
For many patients, air fluidized therapy beds are a better solution than conventional round therapy beds, but, due to their special features, the manufacturing costs associated with these beds are very high. Additionally, the maintenance costs are likely to be too high for the hospital as well as the patients which further hinder the growth of these beds in the market. As a result, the cost of air-fluidized therapy beds restricts their future growth in the market.
Principal Consultant
| Countries | Market Share (2022) |
|---|---|
| United States | 36% |
| Germany | 8.2% |
| Japan | 3.8% |
North America was the leading market for Air Fluidized Therapy Beds market and the trend is expected to continue into the forecast period owing to the increasing disposable incomes, and growing demand for consumer electronics in the region.
The growing demand for Air Fluidized Therapy Beds for safe packaging purposes due to the increase in online shopping applications is expected to augment the Air Fluidized Therapy Beds market. As per the Future Market Insights analysis, the North American region is forecast to have a 35% total share of the Air Fluidized Therapy Beds market.
North America is expected to be the next dominant region witnessing high adoption rates for the Air Fluidized Therapy Beds market during the forecast period. With a high concentration of manufacturing industries in North America, demand for the Air Fluidized Therapy Beds market is anticipated to rise in the region.
Approximately one-third of the patients in North America have diseases that prevent them from moving, therefore the need for comfortable beds is high in this region. The demand for air fluidized therapy beds in this area is high since these beds are one of the best options available to patients suffering from this condition.
According to this report, air fluidized therapy beds hold a market share of 37.8% by 2022. North American manufacturers typically dominate the global air fluidized bed market without much effort, which helps the region dominate the industry worldwide. Furthermore, the ongoing research and development contribute greatly to the growth of these beds.
Patients are turning towards these beds for home use instead of being hospitalized, resulting in significant growth in the air fluidized therapy bed market. Even though they are expensive, these beds are highly effective and reduce the healing time for pressure injuries such as ulcers, which is why they are so popular in these regions. A variety of research is being conducted to update these beds so that patients with spinal issues also benefit from them.
The use of air fluidized therapy beds in Europe is on the rise due to the increasing awareness regarding the different types of therapies for better recuperation of patients at home in this region. The market share of these beds has grown as more hospitals recommend their use in this region. The market share is expected to reach 28.3% in 2022.
With a growing demand for well-equipped facilities and advanced treatments in homes and hospitals, there is a growing demand for these beds in the market. The growing geriatric population and the presence of chronic diseases in these regions have contributed to the growth of the air fluidized therapy bed market in these regions.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The market has a 5.7% growth potential through 2033.
The global air fluidized therapy bed market size to reach US$ 1,135 million by 2033.
The global air fluidized therapy bed market advanced at a 4.1% HCAGR from 2018 to 2022.
The market is valued at US$ 653.5 million in 2023.
The estimated market share for the North American region is 35%.
From 2023 to 2033, the market share is anticipated to surpass 28.3%.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Product Life Cycle Analysis
3.5. Supply Chain Analysis
3.5.1. Supply Side Participants and their Roles
3.5.1.1. Producers
3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)
3.5.1.3. Wholesalers and Distributors
3.5.2. Value Added and Value Created at Node in the Supply Chain
3.5.3. List of Raw Material Suppliers
3.5.4. List of Existing and Potential Buyer’s
3.6. Investment Feasibility Matrix
3.7. Value Chain Analysis
3.7.1. Profit Margin Analysis
3.7.2. Wholesalers and Distributors
3.7.3. Retailers
3.8. PESTLE and Porter’s Analysis
3.9. Regulatory Landscape
3.9.1. By Key Regions
3.9.2. By Key Countries
3.10. Regional Parent Market Outlook
3.11. Production and Consumption Statistics
3.12. Import and Export Statistics
4. Global Analysis 2018 to 2022 and Forecast, 2023 to 2033
4.1. Historical Market Size Value (US$ Million) & Volume (Units) Analysis, 2018 to 2022
4.2. Current and Future Market Size Value (US$ Million) & Volume (Units) Projections, 2023 to 2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Analysis 2018 to 2022 and Forecast 2023 to 2033, By Indication
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Indication, 2018 to 2022
5.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Indication, 2023 to 2033
5.3.1. Pressure Ulcers
5.3.2. Burns
5.3.3. Other Indications
5.4. Y-o-Y Growth Trend Analysis By Indication, 2018 to 2022
5.5. Absolute $ Opportunity Analysis By Indication, 2023 to 2033
6. Global Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By End User, 2018 to 2022
6.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By End User, 2023 to 2033
6.3.1. Hospitals
6.3.2. Ambulatory Surgical Centers
6.3.3. Other End Users
6.4. Y-o-Y Growth Trend Analysis By End User, 2018 to 2022
6.5. Absolute $ Opportunity Analysis By End User, 2023 to 2033
7. Global Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
7.1. Introduction
7.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Region, 2018 to 2022
7.3. Current Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Region, 2023 to 2033
7.3.1. North America
7.3.2. Latin America
7.3.3. Western Europe
7.3.4. Eastern Europe
7.3.5. South Asia and Pacific
7.3.6. East Asia
7.3.7. Middle East and Africa
7.4. Market Attractiveness Analysis By Region
8. North America Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
8.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
8.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
8.2.1. By Country
8.2.1.1. U.S.
8.2.1.2. Canada
8.2.2. By Indication
8.2.3. By End User
8.3. Market Attractiveness Analysis
8.3.1. By Country
8.3.2. By Indication
8.3.3. By End User
8.4. Key Takeaways
9. Latin America Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
9.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
9.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
9.2.1. By Country
9.2.1.1. Brazil
9.2.1.2. Mexico
9.2.1.3. Rest of Latin America
9.2.2. By Indication
9.2.3. By End User
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Indication
9.3.3. By End User
9.4. Key Takeaways
10. Western Europe Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
10.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
10.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
10.2.1. By Country
10.2.1.1. Germany
10.2.1.2. U.K.
10.2.1.3. France
10.2.1.4. Spain
10.2.1.5. Italy
10.2.1.6. Rest of Western Europe
10.2.2. By Indication
10.2.3. By End User
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Indication
10.3.3. By End User
10.4. Key Takeaways
11. Eastern Europe Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
11.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
11.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
11.2.1. By Country
11.2.1.1. Poland
11.2.1.2. Russia
11.2.1.3. Czech Republic
11.2.1.4. Romania
11.2.1.5. Rest of Eastern Europe
11.2.2. By Indication
11.2.3. By End User
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Indication
11.3.3. By End User
11.4. Key Takeaways
12. South Asia and Pacific Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
12.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
12.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
12.2.1. By Country
12.2.1.1. India
12.2.1.2. Bangladesh
12.2.1.3. Australia
12.2.1.4. New Zealand
12.2.1.5. Rest of South Asia and Pacific
12.2.2. By Indication
12.2.3. By End User
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Indication
12.3.3. By End User
12.4. Key Takeaways
13. East Asia Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
13.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
13.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
13.2.1. By Country
13.2.1.1. China
13.2.1.2. Japan
13.2.1.3. South Korea
13.2.2. By Indication
13.2.3. By End User
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Indication
13.3.3. By End User
13.4. Key Takeaways
14. Middle East and Africa Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
14.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
14.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
14.2.1. By Country
14.2.1.1. GCC Countries
14.2.1.2. South Africa
14.2.1.3. Israel
14.2.1.4. Rest of MEA
14.2.2. By Indication
14.2.3. By End User
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Indication
14.3.3. By End User
14.4. Key Takeaways
15. Key Countries Analysis
15.1. U.S.
15.1.1. Pricing Analysis
15.1.2. Market Share Analysis, 2022
15.1.2.1. By Indication
15.1.2.2. By End User
15.2. Canada
15.2.1. Pricing Analysis
15.2.2. Market Share Analysis, 2022
15.2.2.1. By Indication
15.2.2.2. By End User
15.3. Brazil
15.3.1. Pricing Analysis
15.3.2. Market Share Analysis, 2022
15.3.2.1. By Indication
15.3.2.2. By End User
15.4. Mexico
15.4.1. Pricing Analysis
15.4.2. Market Share Analysis, 2022
15.4.2.1. By Indication
15.4.2.2. By End User
15.5. Germany
15.5.1. Pricing Analysis
15.5.2. Market Share Analysis, 2022
15.5.2.1. By Indication
15.5.2.2. By End User
15.6. U.K.
15.6.1. Pricing Analysis
15.6.2. Market Share Analysis, 2022
15.6.2.1. By Indication
15.6.2.2. By End User
15.7. France
15.7.1. Pricing Analysis
15.7.2. Market Share Analysis, 2022
15.7.2.1. By Indication
15.7.2.2. By End User
15.8. Spain
15.8.1. Pricing Analysis
15.8.2. Market Share Analysis, 2022
15.8.2.1. By Indication
15.8.2.2. By End User
15.9. Italy
15.9.1. Pricing Analysis
15.9.2. Market Share Analysis, 2022
15.9.2.1. By Indication
15.9.2.2. By End User
15.10. Poland
15.10.1. Pricing Analysis
15.10.2. Market Share Analysis, 2022
15.10.2.1. By Indication
15.10.2.2. By End User
15.11. Russia
15.11.1. Pricing Analysis
15.11.2. Market Share Analysis, 2022
15.11.2.1. By Indication
15.11.2.2. By End User
15.12. Czech Republic
15.12.1. Pricing Analysis
15.12.2. Market Share Analysis, 2022
15.12.2.1. By Indication
15.12.2.2. By End User
15.13. Romania
15.13.1. Pricing Analysis
15.13.2. Market Share Analysis, 2022
15.13.2.1. By Indication
15.13.2.2. By End User
15.14. India
15.14.1. Pricing Analysis
15.14.2. Market Share Analysis, 2022
15.14.2.1. By Indication
15.14.2.2. By End User
15.15. Bangladesh
15.15.1. Pricing Analysis
15.15.2. Market Share Analysis, 2022
15.15.2.1. By Indication
15.15.2.2. By End User
15.16. Australia
15.16.1. Pricing Analysis
15.16.2. Market Share Analysis, 2022
15.16.2.1. By Indication
15.16.2.2. By End User
15.17. New Zealand
15.17.1. Pricing Analysis
15.17.2. Market Share Analysis, 2022
15.17.2.1. By Indication
15.17.2.2. By End User
15.18. China
15.18.1. Pricing Analysis
15.18.2. Market Share Analysis, 2022
15.18.2.1. By Indication
15.18.2.2. By End User
15.19. Japan
15.19.1. Pricing Analysis
15.19.2. Market Share Analysis, 2022
15.19.2.1. By Indication
15.19.2.2. By End User
15.20. South Korea
15.20.1. Pricing Analysis
15.20.2. Market Share Analysis, 2022
15.20.2.1. By Indication
15.20.2.2. By End User
15.21. GCC Countries
15.21.1. Pricing Analysis
15.21.2. Market Share Analysis, 2022
15.21.2.1. By Indication
15.21.2.2. By End User
15.22. South Africa
15.22.1. Pricing Analysis
15.22.2. Market Share Analysis, 2022
15.22.2.1. By Indication
15.22.2.2. By End User
15.23. Israel
15.23.1. Pricing Analysis
15.23.2. Market Share Analysis, 2022
15.23.2.1. By Indication
15.23.2.2. By End User
16. Market Structure Analysis
16.1. Competition Dashboard
16.2. Competition Benchmarking
16.3. Market Share Analysis of Top Players
16.3.1. By Regional
16.3.2. By Indication
16.3.3. By End User
17. Competition Analysis
17.1. Competition Deep Dive
17.1.1. Hill-Rom,
17.1.1.1. Overview
17.1.1.2. Product Portfolio
17.1.1.3. Profitability by Market Segments
17.1.1.4. Sales Footprint
17.1.1.5. Strategy Overview
17.1.1.5.1. Marketing Strategy
17.1.1.5.2. Product Strategy
17.1.1.5.3. Channel Strategy
17.1.2. Dolphin System
17.1.2.1. Overview
17.1.2.2. Product Portfolio
17.1.2.3. Profitability by Market Segments
17.1.2.4. Sales Footprint
17.1.2.5. Strategy Overview
17.1.2.5.1. Marketing Strategy
17.1.2.5.2. Product Strategy
17.1.2.5.3. Channel Strategy
17.1.3. AURORA MFG,
17.1.3.1. Overview
17.1.3.2. Product Portfolio
17.1.3.3. Profitability by Market Segments
17.1.3.4. Sales Footprint
17.1.3.5. Strategy Overview
17.1.3.5.1. Marketing Strategy
17.1.3.5.2. Product Strategy
17.1.3.5.3. Channel Strategy
17.1.4. American Medical Equipment
17.1.4.1. Overview
17.1.4.2. Product Portfolio
17.1.4.3. Profitability by Market Segments
17.1.4.4. Sales Footprint
17.1.4.5. Strategy Overview
17.1.4.5.1. Marketing Strategy
17.1.4.5.2. Product Strategy
17.1.4.5.3. Channel Strategy
17.1.5. Blue Chip Medical
17.1.5.1. Overview
17.1.5.2. Product Portfolio
17.1.5.3. Profitability by Market Segments
17.1.5.4. Sales Footprint
17.1.5.5. Strategy Overview
17.1.5.5.1. Marketing Strategy
17.1.5.5.2. Product Strategy
17.1.5.5.3. Channel Strategy
17.1.6. Akthel Healthcare BV
17.1.6.1. Overview
17.1.6.2. Product Portfolio
17.1.6.3. Profitability by Market Segments
17.1.6.4. Sales Footprint
17.1.6.5. Strategy Overview
17.1.6.5.1. Marketing Strategy
17.1.6.5.2. Product Strategy
17.1.6.5.3. Channel Strategy
17.1.7. ArjoHuntleigh
17.1.7.1. Overview
17.1.7.2. Product Portfolio
17.1.7.3. Profitability by Market Segments
17.1.7.4. Sales Footprint
17.1.7.5. Strategy Overview
17.1.7.5.1. Marketing Strategy
17.1.7.5.2. Product Strategy
17.1.7.5.3. Channel Strategy
17.1.8. Envella
17.1.8.1. Overview
17.1.8.2. Product Portfolio
17.1.8.3. Profitability by Market Segments
17.1.8.4. Sales Footprint
17.1.8.5. Strategy Overview
17.1.8.5.1. Marketing Strategy
17.1.8.5.2. Product Strategy
17.1.8.5.3. Channel Strategy
17.1.9. Kinetic Concepts
17.1.9.1. Overview
17.1.9.2. Product Portfolio
17.1.9.3. Profitability by Market Segments
17.1.9.4. Sales Footprint
17.1.9.5. Strategy Overview
17.1.9.5.1. Marketing Strategy
17.1.9.5.2. Product Strategy
17.1.9.5.3. Channel Strategy
17.1.10. Denghuang Medical
17.1.10.1. Overview
17.1.10.2. Product Portfolio
17.1.10.3. Profitability by Market Segments
17.1.10.4. Sales Footprint
17.1.10.5. Strategy Overview
17.1.10.5.1. Marketing Strategy
17.1.10.5.2. Product Strategy
17.1.10.5.3. Channel Strategy
17.1.11. Redactron International BV
17.1.11.1. Overview
17.1.11.2. Product Portfolio
17.1.11.3. Profitability by Market Segments
17.1.11.4. Sales Footprint
17.1.11.5. Strategy Overview
17.1.11.5.1. Marketing Strategy
17.1.11.5.2. Product Strategy
17.1.11.5.3. Channel Strategy
17.1.12. Shandong Hesheng Medical Equipment Co., Ltd.
17.1.12.1. Overview
17.1.12.2. Product Portfolio
17.1.12.3. Profitability by Market Segments
17.1.12.4. Sales Footprint
17.1.12.5. Strategy Overview
17.1.12.5.1. Marketing Strategy
17.1.12.5.2. Product Strategy
17.1.12.5.3. Channel Strategy
18. Assumptions & Acronyms Used
19. Research Methodology
Healthcare
October 2024
REP-GB-6348
223 pages
Explore Healthcare Insights
View Reports
Air Fluidized Therapy Beds Market
